A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology (Q34992817)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology |
scientific article |
Statements
1 reference
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology (English)
1 reference
George H Yoo
1 reference
James Moon
1 reference
Michael Leblanc
1 reference
Fulvio Lonardo
1 reference
Susan Urba
1 reference
Harold Kim
1 reference
Ehab Hanna
1 reference
Terry Tsue
1 reference
Joseph Valentino
1 reference
John Ensley
1 reference
Gregory Wolf
1 reference
1 September 2009
1 reference
1 reference
135
1 reference
9
1 reference
869-874
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference